Senior Manager, Accounting and Tax, Controllership, Japan at Bristol-Myers Squibb

Kariya-shi, Aichi, Japan

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, BiotechnologyIndustries

Requirements

Undergraduate degree in accounting, finance or related field
CPA, MBA or equivalent qualification
Knowledge of Japan GAAP and Japan tax regulations

Responsibilities

Oversee and review month-end/quarter-end/year-end closes including BS/PL analysis managed by LE CoE, Stat CoE and capability centers
Ensure financial statements are accurate, complete and in accordance with accounting standards (USGAAP and JPGAAP)
Manage Corporate Income Tax, Consumption Tax, Office Tax, Fixed Asset Tax, Withholding income tax, Revenue stamp tax and Transfer Pricing/APA taxes for BMSKK and BMS Hanbai KK
Manage respective local tax filings, including supporting outsourced Corporate Income Tax and Consumption Tax filing process, and ensure compliance with local market requirements
Facilitate external/internal audits and manage interactions with auditors, collaborating with Legal Entity CoE, Statutory CoE and other capability centers
Facilitate tax audits and manage interactions with auditors/authorities, PwC tax team and Tax CoE
Collaborate with Tax CoE and Corporate Transfer Pricing team to align on critical Tax and TP related topics
Oversee budgeting/projections for Legal Entity (LE) profitability, quarterly profitability adjustment process and monitoring Transfer Price changes managed by LE CoE
Oversee Intercompany back charges, alliance related transactions and pension activities managed by LE CoE, Stat CoE and other capability centers
Engage as a Local Technical Accounting Network (TAN) and collaborate with Corporate TAN for USGAAP and finance SOP updates
Liaise with Controllers Team, Corporate Treasury, LE CoE, Stat CoE and other capability centers to contribute to a high-performance culture with an enterprise mindset
Engage as a Subject Matter Expert for cross-functional projects and as advisor on Statutory and USGAAP requirements
Establish relationships and cross-functional partnerships through integrity to create business value and meet organizational objectives and governance responsibilities
Utilize influence skills to obtain positive outcomes and make decisions aligned with organizational strategy
Drive team performance by promoting participation, sharing of ideas aligned with strategy and maximizing goals
Create a workplace where employees are inspired, encouraged and valued

Skills

USGAAP

JPGAAP

Month-end Close

Quarter-end Close

Year-end Close

BS Analysis

PL Analysis

Corporate Income Tax

Consumption Tax

Fixed Asset Tax

Withholding Tax

Transfer Pricing

Tax Filing

Financial Reporting

Statutory Filing

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free